List your tool

Head to head · 2026

Enlitic vs Qureight

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Enlitic

Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first…

3.9Not listed

Visit Enlitic (opens Enlitic in a new tab)

Qureight

Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab

4.1Not listed

Visit Qureight (opens Qureight in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Enlitic does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Qureight

    3.9 against 4.1

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onEnliticQureight
Our rating3.94.1Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • CXR-AI - deep-learning chest X-ray abnormality detection
  • ENDEX - AI-based medical image data standardization
  • Curie platform for real-world evidence data infrastructure
  • Regulatory approval to commercialize in Japan
  • Measured 20%+ faster radiologist interpretation in early trials
  • Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
  • Glass8 and Vascul8 for vascular and parenchymal measures
  • Central reads and endpoint discovery for trials
  • Imaging data curation and quality control
  • Built for pulmonary fibrosis, hypertension and bronchiectasis trials
Pros
  • Regulatory approval (Japan) is a concrete, third-party-verifiable claim
  • Measured clinical performance gains (speed, true/false positive rates), not just marketing claims
  • ENDEX addresses the unglamorous but real problem of inconsistent imaging-archive labeling
  • Consistent measurement reduces the variability that costs trial power
  • Named biomarkers rather than a generic imaging claim
  • Focused deeply on respiratory and cardiac disease
Cons
  • Enterprise healthcare infrastructure - not accessible to individual practitioners or consumers
  • No published pricing - a hospital/health-system sales process
  • Regulatory approval varies by country - Japan approval doesn't guarantee approval elsewhere
  • No published pricing; sold to trial sponsors
  • Biomarkers need regulatory acceptance per context of use
  • Narrow therapeutic focus by design
CompanyEnliticQureight Ltd

Prices come from each vendor's pricing page, last checked 20260824. Check the vendor before you buy.

FAQ

Questions people ask

Is Enlitic better than Qureight?

In our reviews Enlitic scores 3.9 and Qureight scores 4.1. The better pick depends on the job. Enlitic: Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first U.S. imaging AI company approved to commercialize in Japan. Qureight: Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab.

Which is cheaper, Enlitic or Qureight?

Enlitic: see pricing. Qureight: see pricing.

Do Enlitic and Qureight have free plans?

Neither lists a free plan.

More comparisons